TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
VKTX

Viking Therapeutics Inc

Healthcare · Biotechnology

29.40$ -0.5% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Viking Therapeutics Inc (VKTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.5% of the shares are freely tradable; institutional investors hold 64.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 64.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 97.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 20.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 117Mio.

Largest Shareholders

Institutions

Institutions VKTX
Name Stake (%) Shares Change (%) Date
BlackRock Inc 5.90 6,880,290 +4.1 03/31/2026
FMR Inc 5.16 6,024,753 -8.1 03/31/2026
Vanguard Capital Management, LLC 4.30 5,012,502 +0.0 03/31/2026
Vanguard Portfolio Management, LLC 3.83 4,464,298 +0.0 03/31/2026
State Street Corp 3.77 4,395,557 -1.1 03/31/2026
Two Sigma Investments LLC 3.38 3,937,414 -11.2 06/30/2026
Morgan Stanley - Brokerage Accounts 2.58 3,013,928 -2.0 03/31/2026

Funds

Funds VKTX
Name Stake (%) Shares Change (%) Date
State Street® SPDR® S&P® Biotech ETF 3.24 3,779,939 -1.1 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.01 3,514,949 +0.4 07/31/2026
Vanguard Small Cap Index 2.17 2,536,065 +0.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings VKTX
Person Role Shares Value As of Type
Lian Brian President & CEO 2,572,441 75,629,765 $ Jul 29, 2026 direct
Mancini Marianna Chief Operating Officer 422,760 12,429,144 $ Jul 29, 2026 direct
Zante Greg Chief Financial Officer 212,204 6,238,798 $ Jul 29, 2026 direct
Kelly-Gemmell Dorothy Elizabeth Director 6,333 186,190 $ Aug 1, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 1, 2026 Kelly-Gemmell Dorothy Elizabeth Director Other 6,333 0.00
Jul 29, 2026 Lian Brian President & CEO Sell 148,517 33.32 4,947,888
Jul 29, 2026 Zante Greg Chief Financial Officer Sell 21,217 33.47 710,141
Jul 29, 2026 Mancini Marianna Chief Operating Officer Sell 18,217 33.47 609,636
Jul 28, 2026 Lian Brian President & CEO Other 221,667 0.00
Jul 28, 2026 Zante Greg Chief Financial Officer Other 31,667 0.00
Jul 28, 2026 Mancini Marianna Chief Operating Officer Other 31,667 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?